1997
DOI: 10.1084/jem.186.3.365
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2

Abstract: Nitric oxide (NO) is an important mediator of the inflammatory response. MRL–lpr/lpr mice overexpress inducible nitric oxide synthase (NOS2) and overproduce NO in parallel with the development of an autoimmune syndrome with a variety of inflammatory manifestations. In previous studies, we showed that inhibiting NO production with the nonselective nitric oxide synthase (NOS) inhibitor NG-monomethyl–arginine reduced glomerulonephritis, arthritis, and vasculitis in MRL–lpr/lpr mice. To define further the role of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
49
1
1

Year Published

1998
1998
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(54 citation statements)
references
References 32 publications
(52 reference statements)
3
49
1
1
Order By: Relevance
“…Thus, the studies described here involving the effects of the oxidants on the business end of the Ab molecules, the Ag binding domains, suggest that one of the possible beneficial effects of NO and oxygen radicals may reside in their ability to decrease the formation of immunocomplexes. Pertinent to this discussion is the observation that rodents with absent inducible NO synthase developed inflammatory arthritis of similar magnitude to their wild-type counterparts (25,26), although other pathologic processes such as vasculitis were ameliorated (26).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the studies described here involving the effects of the oxidants on the business end of the Ab molecules, the Ag binding domains, suggest that one of the possible beneficial effects of NO and oxygen radicals may reside in their ability to decrease the formation of immunocomplexes. Pertinent to this discussion is the observation that rodents with absent inducible NO synthase developed inflammatory arthritis of similar magnitude to their wild-type counterparts (25,26), although other pathologic processes such as vasculitis were ameliorated (26).…”
Section: Discussionmentioning
confidence: 99%
“…Oral administration of either N G -monomethyl-L-arginine, a nonspecific NOS inhibitor, or L-N 6− (1-iminoethyl) lysine (L-NIL), an iNOS-specific inhibitor, prevented the development of glomerulonephritis, reduced the intensity of arthritis, and lowered renal pathology scores in MRL-lpr/lpr mice [63]. However, MRL/lpr iNOS knockout mice develop renal disease similar to the wild-type animal [64]. Belmont and colleagues reported elevated serum nitrite levels, an in vivo marker of NO production, in lupus patients [65,66].…”
Section: Nitric Oxide Induced Mitochondrial Biogenesis Mediated Altermentioning
confidence: 99%
“…However, the only available study of glomerulonephritis in NOS-2 Ϫ/Ϫ mice was in a model of mild nephrotoxic nephritis with little M infiltration of glomeruli (29), and apoptosis was not assessed. Furthermore, the equivocal data on NO in glomerulonephritis published to date (in which two studies show amelioration of disease (30,31): two show no difference (29,32), and one shows exacerbation (33)) have concentrated on conventional parameters of glomerular injury rather than apoptosis or remodeling. Therefore, additional experiments will be required to confirm a role for Mderived NO in regulating MC number in glomerulonephritis models exhibiting degrees of M infiltration comparable with that observed in human disease (34,35), in which M number may approach MC number (comparable with the in vitro ratio employed in our experiments).…”
Section: Figurementioning
confidence: 99%